T2 Biosystems is dedicated to saving lives and reducing the cost of healthcare by empowering clinicians to effectively treat patients faster than ever before.
๐ On #InternationalDayOfWomenInScience, we celebrate the incredible contributions of women and girls who drive innovation, discovery, and progress in STEM fields. We are proud to support and work alongside brilliant women advancing science.
#WomenInScience#STEMInnovation
This #SepsisSurvivorsWeek, we honor the strength and resilience of sepsis survivors while raising awareness about the challenges they face. We are committed to advancing rapid diagnostics to enable early detection and targeted treatment, helping save lives and improve outcomes.
๐๏ธ Today, on World Cancer Day, T2 Biosystems recognizes the critical role of innovative diagnostics in detecting life-threatening infections in immunocompromised patients, including those undergoing cancer treatments.
#WorldCancerDay#EarlyDetection#InnovationInDiagnostics
We're excited to share a new case study highlighting how our T2Bacteria Panel played a crucial role in diagnosing culture-negative infective endocarditis.
๐ Read the full case study here: https://t.co/fWpYickgee
#Innovation#Endocarditis#Diagnostics#Healthcare#T2Bacteria
We plan to license our proprietary technology to expand access to direct-from-whole-blood diagnostic capabilities, opening doors for innovations in medical diagnostics for sepsis. Learn more: https://t.co/vufUQf1bkQ
Learn how T2MR is transforming sepsis care with rapid bloodstream infection diagnosis in this webinar!
๐ Date: 12/3/2024
๐ Register: https://t.co/SefNfIohkN
#SepsisAwareness#RapidDiagnostics#Labroots
Today is #WorldAIDSDay ๐ People with HIV/AIDS are at higher risk of infections like sepsis. Early detection is key to better outcomes. Letโs work together for better care and a healthier future. โค๏ธ #SepsisAwareness#T2Biosystems
New clinical case study! ๐จ See how the T2Bacteriaยฎ Panel enabled faster, targeted therapy by detecting a polymicrobial infection. Transforming sepsis care, one diagnosis at a time.
๐ Read more: https://t.co/hzJp3h0WD1
#T2Bacteria#SepsisAwareness#RapidDiagnostics
Missed us at #IDWeek2024? ๐ฅ Our Learning Lounge presentation on T2 Biosystemsโ sepsis panels is now on-demand! Discover how rapid culture-independent diagnostics are transforming patient care. Watch here: https://t.co/gbr34ZCtxS #SepsisAwareness
Itโs U.S. Antibiotic Awareness Week! ๐ฆ ๐ T2 Biosystems supports smarter antibiotic use with rapid diagnostics that enable targeted treatment, reducing unnecessary antibiotics & improving outcomes. Together, we can fight antimicrobial resistance! ๐ #USAAW#AntibioticAwareness
We're excited to share that our distribution partner, #Abalat, is exhibiting at the 54th National Mexican Congress of Clinical Pathology! They are showcasing T2 Biosystemsโ innovative sepsis products, helping to bring faster, more accurate diagnostics to clinicians in Mexico.
Thank you to everyone who stopped by our booth and joined us at our Learning Lounge during #IDWeek2024! ๐ It was a pleasure connecting with you and discussing how our innovative culture-independent diagnostics impact patient care. #HealthcareInnovation#SepsisAwareness
Head over to Learning Lounge 1 at 1:15 pm for the presentation, "Clinical Impact and Innovations of Culture-Independent Diagnostics: A Multidisciplinary Approach for Real-World Application." #IDWeek2024
Join us at booth 740 during #IDWeek2024 for insightful roundtable presentations! ๐ก Discover the latest advancements in pediatric care with T2Candida and explore the latest publications with our Medical Affairs Team. ๐ #HealthcareInnovation#SepsisAwareness#Diagnostics
Welcome to #IDWeek2024! Donโt miss our Learning Lounge session tomorrow at 1:15 PM. Be sure to mark your calendars for an engaging discussion on the future of diagnostics! See you there! ๐ #HealthcareInnovation#Diagnostics
T2 Biosystems and PRxCision have announced a new co-marketing collaboration! Together, weโre advancing personalized medicine by combining T2โs rapid diagnostic capabilities with PRxCisionโs data-driven AI platform. Learn more: https://t.co/jjANAeOtIM
Catch our latest industry session from the 2024 #SepsisSummit, which is now available on our website! The presentation addresses the challenges of Candida infections in the ICU, focusing on implementing the T2Candida Panel to improve #sepsis care. https://t.co/QZpVUFzYuj